Back to search

Institutional Repository of Vilnius University

Genų raiškos pokyčiai skirtingo piktybiškumo krūties navikinėse ląstelių linijose po poveikio si-KRAS arba anti-EGFR /

Abstract

dc:description

Breast cancer is a multifaceted and heterogeneous disease where aberrations in genes, such as EGFR and KRAS, contribute significantly to tumor development, progression, and resistance to therapy. These genes play roles in cellular processes like proliferation, differentiation, and survival. EGFR is a receptor tyrosine kinase, and its overexpression or mutation is associated with aggressive disease and poor prognosis. Similarly, KRAS is a GTPase, and mutations in it lead to constitutive activation of downstream signaling pathways promoting oncogenesis. Therefore, understanding the impact of silencing these genes on the broader gene expression profile in different breast cancer cell lines can shed light on their roles in disease pathophysiology. This study examines the dynamic changes in gene expression in two distinct breast cancer cell lines, MCF-7 and MDA-MB-231, following exposure to gene-silencing methods targeting KRAS isoforms A and B as well as an antibody to the EGFR protein. Both cell lines represent different malignancies within breast cancer, and their molecular response to these silencing methods can provide valuable insights into the underlying mechanisms governing tumour progression and metastasis. Notably, both silencing methods had a significant impact on cellular migration potential, suggesting their influence on the metastatic capacity of these cell lines. The specific gene expression changes reflected both common and unique responses across the cell lines, underscoring the heterogeneity of breast cancer at the molecular level. These findings contribute to our understanding of the complex molecular interactions in breast cancer cells following gene silencing interventions. They provide a foundation for future investigations to further elucidate the role of KRAS and EGFR in breast cancer progression and may inform the development of more effective therapeutic strategies targeting these critical genes in different breast cancer subtypes.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Breimelytė, Dominyka,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Breimelytė, Dominyka,. Genų raiškos pokyčiai skirtingo piktybiškumo krūties navikinėse ląstelių linijose po poveikio si-KRAS arba anti-EGFR /. Institutional Repository of Vilnius University, 2023. https://repository.vu.lt/VU:ELABAETD192828297&prefLang=en_US